Allergic children have more numerous and severe respiratory infections than non-allergic children

Giorgio Ciprandi1, Maria Angela Tosca, Lilia Fasce

  • 1Azienda Ospedaliera Universitaria San Martino, Genova, Italy. gio.cip@libero.it

Insights

Allergic children experience more frequent and longer respiratory infections (RI) compared to non-allergic children. This suggests underlying immune system differences in managing infections.

Area of Science:

  • Pediatric Allergy
  • Immunology
  • Respiratory Medicine

Background:

  • Allergic disorders are linked to Th2-immune polarization.
  • This polarization may impair Th1-dependent mechanisms crucial for fighting respiratory infections (RI).

Purpose of the Study:

  • To compare the incidence and duration of RI in allergic versus non-allergic children with recurrent RI.

Main Methods:

  • A cohort of 117 children (4.02 ± 1.0 years) was studied.
  • 46 children were identified as allergic; the rest were non-allergic.

Main Results:

  • Allergic children had a significantly higher number of RI (mean 1.26 vs. 0.94).
  • Allergic children experienced longer RI durations (mean 8.92 days vs. 4.85 days).

Conclusions:

  • Allergic children exhibit a greater frequency and severity of respiratory infections.
  • Immune dysregulation in allergic conditions may contribute to increased susceptibility to RI.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...